Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren/Amlodipine vs Amlodipine on Ankle-foot Volume in Hypertension
NCT01048047Phase 4Unknown
- Sponsor
- University of Pavia
- Start
- Nov 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aliskiren in hypertension (HTN) (2 arms), sponsored by University of Pavia. Primary endpoints: Blood pressure at 8 weeks, Heart rate at 8 weeks and 1 more. Status: unknown.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01048047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048047.